A recent study suggests that spironolactone, a medication often used as a diuretic, may help stroke survivors manage elevated blood pressure. The REDUCE trial found that participants taking spironolactone achieved lower blood pressure readings and a higher percentage met the recommended blood pressure goal compared to those receiving standard care. While the results are promising, experts highlight that more research is necessary to confirm whether the medication can prevent subsequent strokes.
Key facts
- The REDUCE trial assessed spironolactone's effects on stroke survivors.
- Participants were divided into two groups: one received spironolactone, the other standard care.
- After three months, average blood pressure was 126 for those on spironolactone, compared to 133 for the control group.
- 52% of patients on spironolactone reached the target blood pressure of less than 130/80.
- The trial concluded early with 160 participants instead of the planned 200.
A short AI summary in our own words. The reporting belongs to Fox News — Latest; we don't reproduce it.